Atrial Fibrillation and Anticoagulation
Current BC and Canadian guidelines, algorithms, tools, prescribing references and patient resources for nurse practitioners.
Reviewed by Joe Grafe Due
Review overdue
This page was due for review on October 9, 2027. Check the linked sources for newer versions before relying on it.
Key Sources¶
Thrombosis Canada - Stroke Prevention in Atrial Fibrillation (2024)
Clinical guide for health care professionals. Related guides:
Further Resources¶
2020 CCS/CHRS Comprehensive Guidelines for the Management of Atrial Fibrillation (2020)
Canadian Journal of Cardiology. Cited by the BC guideline. Listed as the current AF guideline on the CHRS guidelines page.
Tools for Practice (CFPCLearn) evidence summaries
Algorithms and Pathways¶
- BC Guidelines: Oral Anticoagulants, Appendix B - Warfarin Reversal Flowchart (2023) · PDF
- Thrombosis Canada: Perioperative Anticoagulant Management Algorithm (online tool)
- Alberta's Pathway Hub: Atrial Fibrillation (2025) — Alberta clinical pathway and referral guideline (referral guideline last updated July 1, 2025); choose "All" when the hub asks for an area
Assessment Tools and Calculators¶
- BC Guidelines: Appendix D - Stroke Risk Assessment in AF, CHADS2 and CHA2DS2-VASc (2023) · PDF
- BC Guidelines: Appendix C - AF Symptom Severity, CCS-SAF Scale (2023) · PDF
- BC Guidelines: Oral Anticoagulants, Appendix A - When to Withhold Antiplatelets and Anticoagulants for Medical Imaging (2023) · PDF
- Thrombosis Canada - CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk — interactive calculator
- Thrombosis Canada - HAS-BLED Score for Major Bleeding Risk — bleeding risk on anticoagulation
Prescribing¶
- BC Guidelines: AF Appendix F - Prescription Medication Tables (2023) · PDF
- BC Guidelines: AF Appendix E - Antithrombotic Therapy in AF with CAD/PAD (2023) · PDF
- BC Guidelines: DOACs Appendix B - Switching Between Anticoagulant Therapies (2023) · PDF
- BC Guidelines: Warfarin Appendix A - Important Interactions with Warfarin (2023) · PDF
- PharmaCare Special Authority Request: Dabigatran for Atrial Fibrillation (HLTH 5391) (2023) · PDF
- Thrombosis Canada clinical guides (version dates as stated by Thrombosis Canada):
- RxFiles: Atrial Fibrillation Anticoagulation Colour Comparison Chart (2025) · PDF
Ontario Drug Benefit - Exceptional Access Program (EAP) (2026)
Ontario coverage for drugs not on the ODB Formulary; nurse practitioners submit requests through SADIE
Advice and Referral¶
- BC Guidelines: Indications for Potential Specialist Referral (2023)
- RACE - Rapid Access to Consultative Expertise — telephone and app advice from BC specialists for family physicians, nurse practitioners and midwives
- Pathways BC - Cardiology — login; specialists and clinics, with referral details
- Ontario eConsult (OTNhub) — specialist advice for Ontario physicians and nurse practitioners, usually without a patient referral
Patient Resources¶
- Patient Record Sheet: DOACs Before and After Procedures (BC GPAC) (2023) · PDF
- Patient Record Sheet: Warfarin Before and After Procedures (BC GPAC) (2023) · PDF
- HealthLink BC - Atrial Fibrillation
- Heart & Stroke - Atrial fibrillation
Also known as: afib, a-fib, AF, atrial flutter, anticoagulant, DOAC, NOAC, apixaban, Eliquis, rivaroxaban, Xarelto, dabigatran, edoxaban, warfarin, INR, CHADS, CHADS65